Layn Natural Ingredients Acquires $1.5 Million in Ispire's Initial Public Offering

Market by Shenzhen Stock Exchange; Rui Tian
Apr.11.2023
CBD manufacturer Ispire is listed on the NASDAQ stock exchange in the US, with an issue price of $7.00. Layn Natural Ingredients purchased 214,285 shares of Ispire's public offering using its own funds, totaling $1.5 million.

On April 4th, CBD manufacturer Ispire went public on the NASDAQ stock exchange in the United States, issuing 2.7 million common shares at a price of $7.00 per share.

 

Layn Natural Ingredients is a domestic plant extraction industry enterprise mainly engaged in the research, production, and sales of plant standardization extraction and high-purity active monomers.

 

Nebulization products are an important downstream application field of industrial cannabis. According to Frost Sullivan's research data, from 2018 to 2022, the global market size of electronic nebulization devices has an annual growth rate of 18.1%, and it is expected to maintain a growth rate of around 18.5% from 2022 to 2027.

 

Layn Natural Ingredients obtained Ispire's first public offering shares allocation with its own funds

 

On April 7th, Layn Natural Ingredients announced that it used its own funds of $1,499,995 to obtain an allocation of 214,285 shares of Ispire (stock abbreviation "ISPR") in its first public offering on the NASDAQ at a price of $7.00 per share. The shares offered in this IPO were listed on the NASDAQ on April 4, 2023 (local time in the United States).

 

It is beneficial for cooperation in the cannabis field

 

Layn Natural Ingredients stated that its participation in Ispire's IPO strategic placement is to promote deeper cooperation between the two parties in the industrial cannabis business, combining their respective sales channels and other resources to achieve win-win cooperation.

Ispire closed at $7.55 on the first day of its listing, an increase of 7.86%, with a market value of $400 million. As of now, the latest stock price is $7.00, and the latest market value is $368.7 million.

 

Also read:

[1] CBD manufacturer Ispire completes its first public offering, raising $18.9 million

[2] CBD manufacturer Ispire announces the pricing of its first public offering: $7 per share, issuing 2.7 million shares

 

Reference:

[1] Layn Natural Ingredients: Announcement on Obtaining Ispire's First Public Offering Shares Allocation and Listing

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

Reuters: Shopify May Ban All Vape Sales This Week Amid Illegal Market Crackdown
Reuters: Shopify May Ban All Vape Sales This Week Amid Illegal Market Crackdown
Reuters reported that Shopify may ban all vape products from its platform as soon as this week, signaling that U.S. enforcement against the illegal vape market is expanding from retailers and importers to e-commerce platforms and payment networks.
MarketBAT
Jun.23 by 2Firsts Perspectives
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices
Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices
The Maine Legislature has passed LD 1519, a bill that would establish a producer-funded stewardship program for electronic smoking devices, requiring manufacturers and importers to manage the collection, transportation, recycling and disposal of end-of-life products, particularly disposable vapes containing lithium-ion batteries.
Jun.12
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12